{
  "title": "Cancer Therapy Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "cancer-therapy-market",
  "industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/cancer-therapy-market",
  "scraped_at": "2026-09-17T17:43:32+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 269.55,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 446.89,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 10.64,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "Medium"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "How large is the cancer therapy market at present?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The cancer therapy market size was USD 269.55 billion in 2026 and is forecast to reach USD 446.89 billion by 2031, growing at a 10.64% CAGR."
      }
    },
    {
      "@type": "Question",
      "name": "Which therapy type is expanding the quickest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Cell and gene therapy is projected to grow at a 12.5% CAGR through 2031 as manufacturing scale and allogeneic platforms lower costs."
      }
    },
    {
      "@type": "Question",
      "name": "Which geographic region is advancing fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific leads growth with an 11.20% CAGR, driven by China's reimbursement expansions and India's biosimilar approvals."
      }
    },
    {
      "@type": "Question",
      "name": "What share do hospitals hold in delivery of oncology care?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Hospitals accounted for 62.40% of spending in 2025, though home-care channels are rising at 11.72% CAGR as payers push for lower-cost settings."
      }
    },
    {
      "@type": "Question",
      "name": "How significant are biosimilars to future pricing?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Biosimilars captured 29% of Avastin's U.S. volume within 18 months, and similar erosion across monoclonal antibody franchises is expected to intensify price competition."
      }
    },
    {
      "@type": "Question",
      "name": "Which companies dominate current sales?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Roche, Bristol Myers Squibb, Merck, AstraZeneca, and Novartis together held 38% of global revenue in 2025, reflecting moderate market concentration."
      }
    }
  ],
  "images": [
    "images/cancer-therapy-market-size.png",
    "images/cancer-therapy-market-major-players.png",
    "images/cancer-therapy-market-share-by-therapy-type.png",
    "images/cancer-therapy-market-share-by-route-of-administration.png",
    "images/cancer-therapy-market-growth-rate-by-region.png",
    "images/cancer-therapy-market-competitive-landscape-market-concentration.png",
    "images/market-snapshot.png",
    "images/pdf3.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/cancer-therapy-market-size.png"
  ],
  "sections_count": 14
}